AstraZeneca and young people, Cts opinion awaited

Spotlights turned on the AstraZeneca vaccine, on the rare cases of thrombosis, and on the administration to young people and women, especially after the two cases of young people hospitalized in Genoa. In Liguria, the health company Alisa, as a precaution, “has instructed all vaccination centers to suspend, until further notice, the administration of batch ABX1506, if present”. Read also After the meeting that took place yesterday, according to what is learned, the CTS is drafting a technical opinion on the administration of AstraZeneca, it being understood that the competence on vaccines remains with the Directorate General of Health Prevention of the Ministry of Health. A position that would also emerge yesterday during the meeting attended by the Minister of Health, Roberto Speranza, and the extraordinary commissioner for the Covid-19 emergency, Francesco Paolo Figliuolo. The president of the Italian Medicines Agency (Aifa) and member of the CTS, Giorgio Palù, this morning stressed that on the subject “it will be the full minister who will say what the decision will be”.